Abbott Laboratories (ABT) Q3 2024 Earnings Call Highlights: Strong Growth in Diabetes Care and ...

CEO Robert Ford discusses the performance of different divisions in Q3 earnings call. Despite some challenges, strong performance in devices and growth in international markets give confidence in meeting full-year guidance.